All Stories

  1. Telehealth as a Strategy to Expand Access in Brazil’s Unified Health System (SUS): An Analysis of São Paulo State’s Experience Across the Three Levels of Healthcare (Preprint)
  2. Quantitative Chest Computed Tomography and Machine Learning for Subphenotyping Small Airways Disease in Long COVID
  3. Community-Acquired Acute Kidney Injury and Late Kidney Dysfunction in Survivors of COVID-19 Hospitalization
  4. Renal Long COVID: A Scoping Review
  5. Correlation between fatigue and pulmonary involvement in the post-COVID-19 condition: a cross-sectional study 6–12 months after hospital discharge
  6. Post‐Discharge COVID ‐19 Symptoms Predict 1‐Year Functional Decline, Falls, and Emergency Department Visits: A Cohort Study
  7. Mechanisms of exercise limitation and pulmonary rehabilitation in patients with cystic lung diseases
  8. Telehealth Initiative to Enhance Primary Care Access in Brazil (UBS+Digital Project): Multicenter Prospective Study
  9. Author Correction: Neuroleptics used in critical COVID associated with moderate-severe dyspnea after hospital discharge
  10. Estimated carbon emissions and support cost savings to telemedicine for patients with tracheal diseases
  11. Neuroleptics used in critical COVID associated with moderate-severe dyspnea after hospital discharge
  12. Inteligência Artificial no Monitoramento em Unidade de Terapia Intensiva (UTI)
  13. Brazilian Thoracic Association recommendations for the management of lymphangioleiomyomatosis
  14. Challenges and Opportunities in Teaching and Training Pediatric Cardiac Critical Care in Developing Countries: A Narrative Review
  15. Predictors of persistent fatigue one year after severe COVID-19: A prospective cohort study on depression and lung function
  16. Joint statement on evidence-based practices in mechanical ventilation: suggestions from two Brazilian medical societies
  17. High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure
  18. Respiratory Effects of Maximal Lung Recruitment Maneuvers Using Single-Breath Estimation in ARDS
  19. Acute respiratory distress syndrome and acute kidney injury in critically ill patients: a scoping review protocol about the lung-kidney crosstalk
  20. Clinical and Functional Outcomes Associated with Quality of Life in Patients with Lymphangioleiomyomatosis: A Cross-Sectional Study
  21. Mobility Levels of Critically Ill Adult Patients and Extubation Success: A Cohort Study
  22. Epidemiology, ventilation management and outcomes of COVID–19 ARDS patients versus patients with ARDS due to pneumonia in the Pre–COVID era
  23. Impact of extended lung protection during mechanical ventilation on lung recovery in patients with COVID-19 ARDS: a phase II randomized controlled trial
  24. Graphene oxide microstrip antenna-based sensor for oxygen gas sensing in medical applications
  25. Implementation and Results of a Dedicated Telemedicine Program (TeleTrachea) for Patients with Tracheal Diseases
  26. Post-COVID-19 respiratory sequelae two years after hospitalization: an ambidirectional study
  27. Post-COVID-19 condition: systemic inflammation and low functional exercise capacity
  28. Temporal trends of severity and outcomes of critically ill patients with COVID-19 after the emergence of variants of concern: A comparison of two waves
  29. Long COVID and kidney function: A scoping review protocol
  30. Data-driven, cross-disciplinary collaboration: lessons learned at the largest academic health center in Latin America during the COVID-19 pandemic
  31. Differences of ventilatory muscle recruitment and work of breathing in COPD and interstitial lung disease during exercise: a comprehensive evaluation
  32. Clinical, tomographic and functional comparison of sporadic and tuberous sclerosis complex-associated forms of lymphangioleiomyomatosis: a retrospective cohort study
  33. The impact of obesity in hospitalized patients with COVID-19: a retrospective cohort study
  34. Small airways morphological alterations associated with functional impairment in lymphangioleiomyomatosis
  35. Association among cardiopulmonary and metabolic rehabilitation, arrhythmias, and myocardial ischemia responses of patients with HFpEF or HFmrEF
  36. A comprehensive physical functional assessment of survivors of critical care unit stay due to COVID-19
  37. Risk Factors for the Impairment of Ambulation in Older People Hospitalized with COVID-19: A Retrospective Cohort Study
  38. Risk Factors for the Impairment of Ambulation in Older People Hospitalized with Covid-19: A Retrospective Cohort Study
  39. Feasibility of neck electrical impedance tomography to monitor upper airway dynamics during sleep
  40. Breathing Under Pressure: An exploratory analysis of differences in respiratory muscle activity and work of breathing during exercise in COPD and ILD
  41. Telemedicine as a tool in the smoking cessation clinic – 154 cases in 2 years in the largest city in Latin America.
  42. Telemedicine in Brazil: Teleconsultations at the Largest University Hospital in the Country
  43. Respiratory arousal threshold among patients with isolated sleep apnea and with comorbid insomnia (COMISA)
  44. Thoracic endometriosis presenting as diffuse cystic lung disease: a rare case report
  45. Tele-Intensive Care Unit Program in Brazil: Implementation and Expansion
  46. A novel wireless oxygen gas sensor based on silver film loaded on a patch antenna
  47. Twelve Months and Counting: Following Clinical Outcomes in Critical COVID-19 Survivors
  48. Long-term respiratory follow-up of ICU hospitalized COVID-19 patients: Prospective cohort study
  49. User Experience Regarding Digital Primary Health Care in Santarém, Amazon: Evaluation of Patient Satisfaction and Doctor’s Feedback
  50. Post-acute sequelae of SARS-CoV-2 associates with physical inactivity in a cohort of COVID-19 survivors
  51. Análise da satisfação de pacientes Pós-COVID-19 com telemonitoramento para o treinamento da musculatura inspiratória
  52. Functional impact on adults and older people after hospitalization by Covid‐19
  53. Increased risk of death from COVID-19 during peak of cases
  54. Validation of an overnight wireless high-resolution oximeter for the diagnosis of obstructive sleep apnea at home
  55. A Convolutional Neural Network Approach to Quantify Lung Disease Progression in Patients with Fibrotic Hypersensitivity Pneumonitis (HP)
  56. Clinical, sociodemographic and environmental factors impact post-COVID-19 syndrome
  57. Evaluation of maximal exercise capacity through the incremental shuttle walking test in lymphangioleiomyomatosis
  58. Post-acute sequelae of SARS-CoV-2 infection: relationship of central nervous system manifestations with physical disability and systemic inflammation – CORRIGENDUM
  59. Chronic lung lesions in COVID-19 survivors: predictive clinical model
  60. COVID-19 in Lymphangioleiomyomatosis
  61. Association between chemosensory impairment with neuropsychiatric morbidity in post-acute COVID-19 syndrome: results from a multidisciplinary cohort study
  62. Post-acute sequelae of SARS-CoV-2 infection: relationship of central nervous system manifestations with physical disability and systemic inflammation
  63. High flow nasal catheter therapy versus non-invasive positive pressure ventilation in acute respiratory failure (RENOVATE trial): protocol and statistical analysis plan
  64. Brazilian guidelines for the treatment of outpatients with suspected or confirmed COVID-19. A joint guideline of the Brazilian Association of Emergency Medicine (ABRAMEDE), Brazilian Medical Association (AMB), Brazilian Society of Angiology and Vascula...
  65. Post-COVID-19 psychiatric and cognitive morbidity: Preliminary findings from a Brazilian cohort study
  66. Something not so new for lymphangioleiomyomatosis: is VEGF-D a glass half empty or half full?
  67. Quantitative CT Analysis in Chronic Hypersensitivity Pneumonitis: A Convolutional Neural Network Approach
  68. Patient-Centered Outcomes Following COVID-19: Frailty and Disability Transitions in Critical Care Survivors*
  69. Timing to Intubation COVID-19 Patients: Can We Put It Off until Tomorrow?
  70. Correction to: A comparison of endotracheal tube compensation technique for the measurement of respiratory mechanical impedance at low frequencies
  71. Distinct Outcomes in COVID-19 Patients with Positive or Negative RT-PCR Test
  72. Ambulation capacity, age, immunosuppression, and mechanical ventilation are risk factors of in-hospital death in severe COVID-19: a cohort study
  73. Erratum to “Persistent symptoms and decreased health-related quality of life after symptomatic pediatric COVID-19: A prospective study in a Latin American tertiary hospital” [Clinics. 2021;76:e3511]
  74. A comparison of endotracheal tube compensation techniques for the measurement of respiratory mechanical impedance at low frequencies
  75. Texture-based classification of lung disease patterns in chronic hypersensitivity pneumonitis and comparison to clinical outcomes
  76. Acute exacerbation of post-COVID-19 pulmonary fibrosis: air travel as a potential trigger
  77. Association between functionality and respiratory impairment after hospitalization for COVID-19: a cohort study
  78. Hold your breath again: Exploring dysfunctional breathing assessments in healthy individuals
  79. Desaturation-distance ratio during field exercise test in lymphangioleiomyomatosis: a cross-sectional study
  80. Ventilatory Variables and Mechanical Power in Patients with Acute Respiratory Distress Syndrome
  81. Desaturation-Distance Ratio During Submaximal and Maximal Exercise Tests and Its Association With Lung Function Parameters in Patients With Lymphangioleiomyomatosis
  82. Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an Antifungal Diagnostic Driven Approach
  83. COVID‐19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes
  84. Association of the mobility level of critically ill adult patients with the success of extubation: protocol for a cohort study
  85. Association between pulmonary artery to aorta diameter ratio with pulmonary hypertension and outcomes in diffuse cystic lung diseases
  86. Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil
  87. Implementation of Tele-ICU during the COVID-19 pandemic
  88. Thoracoabdominal asynchrony associates with exercise intolerance in fibrotic interstitial lung diseases
  89. Tracking the time course of pathological patterns of lung injury in severe COVID-19
  90. Unilateral diaphragmatic paralysis: inspiratory muscles, breathlessness and exercise capacity
  91. Protocol for Functional Assessment of Adults and Older Adults after Hospitalization for COVID-19
  92. Differences in children and adolescents with SARS-CoV-2 infection: a cohort study in a Brazilian tertiary referral hospital
  93. Persistent symptoms and decreased health-related quality of life after symptomatic pediatric COVID-19: A prospective study in a Latin American tertiary hospital
  94. Mechanisms of Exercise Limitation and Prevalence of Pulmonary Hypertension in Pulmonary Langerhans Cell Histiocytosis
  95. The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline
  96. Diffuse cystic lung disease as the primary tomographic manifestation of bronchiolitis: A case series
  97. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19
  98. Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis
  99. COVID‐19 and lymphangioleiomyomatosis: Experience at a reference center and the potential impact of the use of mTOR inhibitors
  100. Physical activity levels in women with lymphangioleiomyomatosis
  101. Incremental shuttle walking test evaluates the maximal exercise capacity of patients with lymphangioleiomyomatosis
  102. Natural history of incidental sporadic and tuberous sclerosis complex associated lymphangioleiomyomatosis
  103. Neurally adjusted ventilatory assist vs. pressure support to deliver protective mechanical ventilation in patients with acute respiratory distress syndrome: a randomized crossover trial
  104. Diaphragmatic ultrasound: a review of its methodological aspects and clinical uses
  105. Characteristics and outcomes of patients with COVID-19 admitted to the ICU in a university hospital in São Paulo, Brazil - study protocol
  106. Use of telemedicine to combat the COVID-19 pandemic in Brazil
  107. Brazilian guidelines for the pharmacological treatment of idiopathic pulmonary fibrosis. Official document of the Brazilian Thoracic Association based on the GRADE methodology
  108. Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in São Paulo state, Brazil, 2010–15: a population-based, longitudinal study
  109. Uncovering the mechanisms of exertional dyspnoea in combined pulmonary fibrosis and emphysema
  110. Diaphragmatic ultrasound findings correlate with dyspnea, exercise tolerance, health-related quality of life and lung function in patients with fibrotic interstitial lung disease
  111. Forced Oscillation Technique and Small Airway Involvement in Chronic Hypersensitivity Pneumonitis
  112. Natural history of incidental sporadic or tuberous sclerosis complex associated lymphangioleiomyomatosis
  113. Pulmonary Hypertension in Pulmonary Langerhans Cell Histiocytosis: prevalence and the role of Cardiopulmonary Exercise Testing and echocardiogram in predicting it
  114. Convolutional neural network (CNN) for interstitial lung disease (ILD) patterns recognition
  115. A textural approach for quantitative CT in chronic hypersensitivity pneumonitis (cHP)
  116. Risk of breast cancer in patients with lymphangioleiomyomatosis
  117. Heterogeneous effects of alveolar recruitment in acute respiratory distress syndrome: a machine learning reanalysis of the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial
  118. A decision-aid tool for ICU admission triage is associated with a reduction in potentially inappropriate intensive care unit admissions
  119. An Unusual Combination of Diffuse Pulmonary Cysts and a Nodule
  120. A Rare Association Between Pulmonary Idiopathic Diffuse Neuroendocrine Hyperplasia and Organizing Pneumonia
  121. Characterization of Airway Disease in Rheumatoid Arthritis</bold>
  122. Effects of Three Levels of Pressure Support Ventilation on Tidal Volume, Inspiratory Time and Peak Inspiratory Flow During Different Inspiratory Efforts: A Bench Study
  123. Hodgkin's Disease Presenting with Dominant Pulmonary Involvement: A Challenging Case
  124. Severe Pulmonary Alveolar Proteinosis in a Patient with GATA2 Deficiency
  125. Differences in the Approach to Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE IPF) Between Expert Centres and General Pulmonologists: Results from an International Survey
  126. Squawks in Interstitial Lung Diseases
  127. Transbronchial Biopsy in Chronic Hypersensitivity Pneumonitis
  128. Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary Fibrosis
  129. Recruitment maneuver might be an option for patients with hypoxemia and atelectasis
  130. Concentration of Serum Vascular Endothelial Growth Factor (VEGF-D) and Its Correlation with Functional and Clinical Parameters in Patients with Lymphangioleiomyomatosis from a Brazilian Reference Center
  131. Imaging in idiopathic pulmonary fibrosis: diagnosis and mimics
  132. Driving pressure and long-term outcomes in moderate/severe acute respiratory distress syndrome
  133. The effects of recruitment maneuver during noninvasive ventilation after coronary bypass grafting: A randomized trial
  134. A global perspective on acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF): results from an international survey
  135. A mismatch between dyspnea and general-respiratory functional tests in patients with Amyotrophic Lateral Sclerosis
  136. Evaluation of exercise capacity and mechanisms of limitation during cardiopulmonary exercise testing (CPET) in patients with chronic hypersensitivity pneumonitis
  137. Unilateral diaphragm paralysis: a dysfunction restricted not just to one hemidiaphragm
  138. Mechanisms of exercise limitation in patients with chronic hypersensitivity pneumonitis
  139. Immunohistological features related to functional impairment in lymphangioleiomyomatosis
  140. Characterization and outcomes of pulmonary alveolar proteinosis in Brazil: a case series
  141. Who are the patients with tuberculosis who are diagnosed in emergency facilities? An analysis of treatment outcomes in the state of São Paulo, Brazil
  142. Diaphragmatic Ultrasound Correlates with Inspiratory Muscle Strength and Pulmonary Function in Healthy Subjects
  143. Lung Recruitment and Positive End-Expiratory Pressure Titration in Patients With Acute Respiratory Distress Syndrome—Reply
  144. Accuracy of Invasive and Noninvasive Parameters for Diagnosing Ventilatory Overassistance During Pressure Support Ventilation*
  145. Should the ART trial change our practice?
  146. Short-term effects of stored homologous red blood cell transfusion on cardiorespiratory function and inflammation: an experimental study in a hypovolemia model
  147. Should the ART trial change our practice?
  148. Impact of Tuberculosis Classification on Treatment Outcomes
  149. Neurally Adjusted Ventilatory Assist (NAVA) or Pressure Support Ventilation (PSV) during spontaneous breathing trials in critically ill patients: a crossover trial
  150. Computed tomography in hypersensitivity pneumonitis: main findings, differential diagnosis and pitfalls
  151. Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome
  152. Vaginal microbiota in asymptomatic Brazilian women with HIV
  153. Exercise in patients with pulmonary Langerhans cell histiocytosis: performance and mechanisms of limitation
  154. Lung function in seated and supine positions to predict diaphragm weakness in diaphragmatic paralysis
  155. Effects of inspiratory muscle training and aerobic training on inspiratory muscle strength in chronic systolic heart failure patients: a pilot study
  156. Concentration of serum vascular endothelial growth factor D and its correlation with functional and clinical variables in patients with lymphangioleiomyomatosis from a Brazilian reference centre
  157. Mechanisms of exercise limitation in patients with combined fibrosis and pulmonary emphysema
  158. Experience of Lung Transplantation in Patients with Lymphangioleiomyomatosis at a Brazilian Reference Centre
  159. Thoracoabdominal Asynchrony Measurement: Comparing Two Methods
  160. Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method
  161. Diffuse cystic lung diseases: differential diagnosis
  162. Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis
  163. Statistical analysis plan for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial (ART). A randomized controlled trial
  164. S97 Annual rate of fvc decline in various patient sub-groups with idiopathic pulmonary fibrosis treated with pirfenidone: pooled analysis from 3 pivotal studies
  165. P174 Effect of continued treatment with pirfenidone following a ≥10% relative decline in percent predicted forced vital capacity (%FVC) in patients with idiopathic pulmonary fibrosis (IPF)
  166. Stability and Agreement of a Microtransducer and an Air-Filled Balloon Esophageal Catheter in the Monitoring of Esophageal Pressure
  167. Diagnostic Approach to Advanced Fibrotic Interstitial Lung Disease: Bringing Together Clinical, Radiologic, and Histologic Clues
  168. Ventilatory muscle strength and ultrasound evaluation of diaphragm in healthy subjects
  169. Diaphragmatic dysfunction evaluated by ultrasound correlates with dyspnea, exercise and quality of life in interstitial lung disease
  170. Pulmonary hyperinflation and postural balance in COPD patients
  171. Effects of age and disease in COPD postural balance
  172. Comparison of thoracoabdominal synchrony using two methods in healthy subjects, chronic obstructive and interstitial lung disease
  173. Colchicine and oryzalin effects on tetraploid induction and leaf anatomy of Solanum commersonii ssp.
  174. miR-155 in the progression of lung fibrosis in systemic sclerosis
  175. Association of Pulmonary Cysts and Nodules in a Young Female Patient
  176. Development of an algorithm to aid triage decisions for intensive care unit admission: a clinical vignette and retrospective cohort study
  177. Identifying decreased diaphragmatic mobility and diaphragm thickening in interstitial lung disease: the utility of ultrasound imaging
  178. The impact of being homeless on the unsuccessful outcome of treatment of pulmonary TB in São Paulo State, Brazil
  179. Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis
  180. Pulmonary rehabilitation in lymphangioleiomyomatosis: a controlled clinical trial
  181. Idiopathic pulmonary fibrosis can be a transient diagnosis
  182. There is no cephalocaudal gradient of computed tomography densities or lung behavior in supine patients with acute respiratory distress syndrome
  183. Open Lung Approach for the Acute Respiratory Distress Syndrome
  184. Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials
  185. Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials
  186. Effects of the open lung concept following ARDSnet ventilation in patients with early ARDS
  187. S109 Effect of continued treatment with pirfenidone following a clinically meaningful decline in percent predicted forced vital capacity in patients with idiopathic pulmonary fibrosis (IPF): Abstract S109 Table 1
  188. P13 Safety of pirfenidone in patients with idiopathic pulmonary fibrosis (IPF): Integrated analysis of cumulative data from 5 clinical trials: Abstract P13 Table 1
  189. My time at the JBP
  190. Evaluation of the impact of a pulmonary rehabilitation program on exercise capacity in LAM
  191. Regional ventilation of patients with hemidiaphragm paralysis by electrical impedance tomography
  192. Benefit of continued pirfenidone treatment following hospitalisation within the first 6 months of therapy—Ad hoc analysis from three phase 3 trials in patients with idiopathic pulmonary fibrosis (IPF)
  193. The contribution of each hemidiaphragm to the overall inspiratory strength in healthy subjects and unilateral diaphragmatic paralysis
  194. Lack of understanding of COPD is associated with a higher physical activity level
  195. The late impact of hospitalization on the daily life physical activity level in patients of COPD
  196. Comparison among different instruments to evaluate the clinical control in asthmatic patients submitted to aerobic training
  197. What if my lung-dominant connective tissue disease (LD-CTD) patient eventually met criteria for a definite CTD: The role of prognosis!
  198. Respiratory muscle strength at rest, during and after maximal exercise in healthy subjects
  199. Volitional and non-volitional strength, synchrony and inspiratory force reserve in fibrosing interstitial lung disease at rest and during exercise
  200. Pulmonary involvement in rheumatoid arthritis: evaluation by radiography and spirometry
  201. Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary Fibrosis
  202. Can Patients Maintain Their Use of Everolimus Until Lung Transplantation?
  203. Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations
  204. Diagnostic methods to assess inspiratory and expiratory muscle strength
  205. Lung-dominant connective tissue disease among patients with interstitial lung disease: prevalence, functional stability, and common extrathoracic features
  206. Driving Pressure and Survival in the Acute Respiratory Distress Syndrome
  207. Endobronchial ultrasound-guided transbronchial needle aspiration for lung cancer staging: early experience in Brazil,
  208. Dyspnea of Unknown Cause. Think about Diaphragm
  209. Mathematical model applied to single-track line scheduling problem in Brazilian railways
  210. Brazilian Journal of Pulmonology and Portuguese Journal of Pulmonology: Strengthening ties in respiratory science
  211. Brazilian recommendations of mechanical ventilation 2013. Part 2
  212. Evaluation of the Extent of Pulmonary Cysts and Their Association with Functional Variables and Serum Markers in Lymphangioleiomyomatosis (LAM)
  213. New steps for the international consolidation of the Brazilian Journal of Pulmonology
  214. Brazilian recommendations of mechanical ventilation 2013. Part I
  215. *
  216. Combined pulmonary fibrosis and emphysema: an increasingly recognized condition
  217. A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
  218. Doxycycline in lymphangioleiomyomatosis: not all questions are answered
  219. Environmental exposure in inflammatory myositis
  220. Severe hypoxemia during veno-venous extracorporeal membrane oxygenation: exploring the limits of extracorporeal respiratory support
  221. Association of Interferon‐ and Transforming Growth Factor β–Regulated Genes and Macrophage Activation With Systemic Sclerosis–Related Progressive Lung Fibrosis
  222. Reconciling Healthcare Professional and Patient Perspectives in the Development of Disease Activity and Response Criteria in Connective Tissue Disease–related Interstitial Lung Diseases
  223. Multiple Benefits of Rehabilitation in a Patient with Heart and Renal Failure
  224. Adalimumab-induced acute interstitial lung disease in a patient with rheumatoid arthritis
  225. Lung ultrasound in the evaluation of pleural effusion
  226. The economic effect of extracorporeal membrane oxygenation to support adults with severe respiratory failure in Brazil: a hypothetical analysis
  227. Varicella associated acute respiratory distress syndrome in an adult patient: an example for extracorporeal respiratory support in Brazilian endemic diseases
  228. Brazilian recommendations of mechanical ventilation 2013. Part I
  229. Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials
  230. A pilot study assessing the effect of bronchodilator on dynamic hyperinflation in LAM
  231. Early Passive Cycling Exercise in Critically Ill Patients: Feasibility and Safety Aspects
  232. Pneumomediastinum, subcutaneous emphysema, and pneumothorax after a pulmonary function testing in a patient with bleomycin-induced interstitial pneumonitis
  233. Evaluation of manual resuscitators used in ICUs in Brazil
  234. The Brazilian Journal of Pulmonology and international databases
  235. Infection as an independent risk factor for mortality in the surgical intensive care unit
  236. Interstitial Emphysema Leading to Pneumomediastinum in a Bone Marrow Transplant Patient
  237. Lung cysts in chronic paracoccidioidomycosis
  238. Experimental study on the efficiency and safety of the manual hyperinflation maneuver as a secretion clearance technique
  239. The lung in paracoccidioidomycosis: new insights into old problems
  240. Doxiciclina em pacientes com linfangioleiomiomatose: biomarcadores e resposta funcional pulmonar
  241. Expression of acute-phase cytokines, surfactant proteins, and epithelial apoptosis in small airways of human acute respiratory distress syndrome
  242. Publicações do Jornal Brasileiro de Pneumologia
  243. Noninvasive ventilation immediately after extubation improves weaning outcome after acute respiratory failure: a randomized controlled trial
  244. Association between systemic corticosteroids and outcomes of intensive care unit–acquired pneumonia*
  245. Rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART): Study protocol for a randomized controlled trial
  246. Exercise Performance and Dynamic Hyperinflation in Lymphangioleiomyomatosis
  247. Divulgação do fator de impacto do Jornal Brasileiro de Pneumologia: consolidação de um longo e árduo trabalho
  248. Destaques das diretrizes de doenças pulmonares intersticiais da Sociedade Brasileira de Pneumologia e Tisiologia
  249. Imunofenotipagem e remodelamento da matriz extracelular na sarcoidose pulmonar e extrapulmonar
  250. Lymphatic fluctuation in the parenchymal remodeling stage of acute interstitial pneumonia, organizing pneumonia, nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis
  251. Linfoadenopatia transitória secundária à síndrome nefrótica
  252. Sleep desaturation and its relationship to lung function, exercise and quality of life in LAM
  253. Oxigenação extracorpórea por membrana na hipoxemia grave: hora de revermos nossos conceitos?
  254. Ocorrência de sintomas asmáticos e de distúrbio obstrutivo em nadadores amadores de 8 a 17 anos de idade
  255. Birt-Hogg-Dubé syndrome: metalloproteinase activity and response to doxycycline
  256. Challenges in patients supported with extracorporeal membrane oxygenation in Brazil
  257. First-year experience of a Brazilian tertiary medical center in supporting severely ill patients using extracorporeal membrane oxygenation
  258. Goal-Oriented Respiratory Management for Critically Ill Patients with Acute Respiratory Distress Syndrome
  259. Avaliação dos artigos de pneumologia publicados em periódicos Brasileiros além do Jornal Brasileiro de Pneumologia
  260. O fator de impacto do Jornal Brasileiro de Pneumologia está chegando
  261. Tunnel excavation triggering pulmonary sarcoidosis
  262. Immunoglobulin G4-related systemic sclerosing disease in a patient with sclerosing cholangitis, inflammatory pseudotumors of the lung and multiple radiological patterns: a case report
  263. Diffuse Micronodules with Spontaneous Resolution
  264. Extracorporeal membrane oxygenation as a bridge to pulmonary transplantation in Brazil: Are we ready to embark upon this new age?
  265. Doxiciclina em pacientes com linfangioleiomiomatose: segurança e eficácia no bloqueio de metaloproteinases
  266. A sigmoidal fit for pressure-volume curves of idiopathic pulmonary fibrosis patients on mechanical ventilation: clinical implications
  267. Pulmonary arterial involvement leading to alveolar hemorrhage in lymphangioleiomyomatosis
  268. Evolução da função pulmonar após tratamento com goserelina em pacientes com linfangioleiomiomatose
  269. Follow-up after acute respiratory distress syndrome caused by influenza a (H1N1) virus infection
  270. The epidemiology of acute respiratory failure in hospitalized patients: A Brazilian prospective cohort study
  271. Adenopathy and Pulmonary Infiltrates in a Japanese Emigrant in Brazil
  272. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
  273. Cell therapy for fibrotic interstitial pulmonary disease: Experimental study
  274. Shortening ventilatory support with a protocol based on daily extubation screening and noninvasive ventilation in selected patients
  275. Small airway remodeling in acute respiratory distress syndrome: a study in autopsy lung tissue
  276. A hora da virada
  277. The Quest for the Holy Grail: A Dead Lock
  278. Atelectasis observed by computerized tomography after Caesarean section
  279. Abnormal expression of telomerase/apoptosis limits type II alveolar epithelial cell replication in the early remodeling of usual interstitial pneumonia/idiopathic pulmonary fibrosis
  280. The International LAM Registry: A Component of an Innovative Web-Based Clinician, Researcher, and Patient-Driven Rare Disease Research Platform
  281. Lung hyperinflation stimulates the release of inflammatory mediators in spontaneously breathing subjects
  282. An evaluation of respiration and swallowing interaction after orotracheal intubation
  283. Continuous flow positive airway pressure generator in critically ill patients
  284. Desaturation – distance ratio: a new concept for a functional assessment of interstitial lung diseases
  285. Effects of proportional assisted ventilation on exercise performance in idiopathic pulmonary fibrosis patients
  286. Biopsy-Proven Pulmonary Determinants of Heart Disease
  287. Small Airway Remodeling in Idiopathic Interstitial Pneumonias: A Pathological Study
  288. Age, invasive ventilatory support and outcomes in elderly patients admitted to intensive care units
  289. Evaluating humidity recovery efficiency of currently available heat and moisture exchangers: a respiratory system model study
  290. Esophageal involvement and interstitial lung disease in mixed connective tissue disease
  291. Frequência de sintomas de asma e de redução da função pulmonar entre crianças e adolescentes nadadores amadores
  292. Lung cyst: An unusual manifestation of Niemann-Pick disease
  293. Ventilation Strategies for Acute Lung Injury and Acute Respiratory Distress Syndrome
  294. Acometimento pulmonar na doença de Behçet: uma boa experiência com o uso de imunossupressores
  295. Continuous positive airway pressure increases inspiratory capacity of COPD patients
  296. Potential Role of Statin Use in Idiopathic Pulmonary Fibrosis
  297. Real-time detection of pneumothorax using electrical impedance tomography*
  298. Remembering Other Causes of Alveolar Siderophages
  299. Adaptação do Bird Mark 7 para oferta de pressão positiva contínua nas vias aéreas em ventilação não-invasiva: estudo em modelo mecânico
  300. Underestimation of Lung Collapse and Under Optimization of a PEEP Trial
  301. Ventilação mecânica na Lesão Pulmonar Aguda (LPA)/Síndrome do Desconforto Respiratório Agudo (SDRA)
  302. Ventilação mecânica: princípios, análise gráfica e modalidades ventilatórias
  303. Ventiladores mecânicos
  304. Functional implications of BAL in the presence of restrictive or obstructive lung disease
  305. Abnormal deposition of collagen/elastic vascular fibres and prognostic significance in idiopathic interstitial pneumonias
  306. Leptospiral pneumonias
  307. Primary Malignant Fibrous Histiocytoma of the Lung
  308. Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study
  309. Comparison of two questionnaires which measure the health-related quality of life of idiopathic pulmonary fibrosis patients
  310. Pathology and pathophysiology of pulmonary manifestations in leptospirosis
  311. Comparison of two questionnaires which measure the health-related quality of life of idiopathic pulmonary fibrosis patients
  312. Is Maximal Lung Recruitment Worth It?
  313. Inflammatory Cell Phenotyping of the Pulmonary Interstitium in Idiopathic Interstitial Pneumonia
  314. The Role of NT-proBNP as a Prognostic Marker in Pulmonary Hypertension
  315. Severe acute respiratory distress syndrome, leptospirosis, and lung protective strategies
  316. Reversibility of Lung Collapse and Hypoxemia in Early Acute Respiratory Distress Syndrome
  317. Structural Features of Epithelial Remodeling in Usual Interstitial Pneumonia Histologic Pattern
  318. Lung Recruitment in Patients with ARDS
  319. The Need for National Registries in Rare Diseases
  320. Consenso em paracoccidioidomicose
  321. Comparison of two flow generators with a noninvasive ventilator to deliver continuous positive airway pressure: a test lung study
  322. LUNG FUNCTION IMPROVEMENTS WITH TIOTROPIUM BROMIDE IN CONSTRICTIVE BRONCHIOLITIS
  323. Nonhomogeneous Density of CD34 and VCAM-1 Alveolar Capillaries in Major Types of Idiopathic Interstitial Pneumonia
  324. Acute vasodilator test in pulmonary arterial hypertension: Evaluation of two response criteria
  325. Congestão pulmonar crônica
  326. Heterogeneous Remodeling of Lung Vessels in Idiopathic Pulmonary Fibrosis
  327. Paradoxical responses to positive end-expiratory pressure in patients with airway obstruction during controlled ventilation*
  328. Collagen and elastic system in the remodelling process of major types of idiopathic interstitial pneumonias (IIP)
  329. N-terminal-pro-brain natriuretic peptide as a haemodynamic marker in idiopathic pulmonary arterial hypertension
  330. Mechanical ventilation in acute respiratory failure: recruitment and high positive end-expiratory pressure are necessary
  331. Pulmonary and mediastinal “sarcoidosis” following surgical resection of cancer
  332. Imbalances in Regional Lung Ventilation
  333. Acute Respiratory Failure after Interferon-γ Therapy in IPF
  334. Lung recruitment maneuvers in acute respiratory distress syndrome
  335. Prevalence rates of infection in intensive care units of a tertiary teaching hospital
  336. A 44-yr-old male with progressive dyspnoea and dry cough
  337. Diffuse panbronchiolitis: an underdiagnosed disease? Study of 4 cases in Brazil
  338. Effectiveness, safety and tolerability of gatifloxacin, a new 8-methoxyfluoroquinolone, in the treatment of outpatients with community-acquired pneumonia: a Brazilian study
  339. Pulmonary complications of leptospirosis
  340. Evaluation of Indoor Exposition to Benzene, Toluene, Ethylbenzene, Xylene, and Styrene by Passive Sampling with a Solid-Phase Microextraction Device
  341. Accuracy of High Resolution CT in Assessing Idiopathic Pulmonary Fibrosis Histology by Objective Morphometric Index
  342. Mask mechanics and leak dynamics during noninvasive pressure support ventilation: a bench study
  343. Different Low Constant Flows Can Equally Determine the Lower Inflection Point in Acute Respiratory Distress Syndrome Patients
  344. Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP)
  345. Analysis of gamma radiation-induced chromosome variations in maize (Zea maysL.)
  346. Protective Ventilation for the Acute Respiratory Distress Syndrome
  347. System of measurement of the transmission spectrum of in-vitro corneas for eye banks
  348. Effect of a Protective-Ventilation Strategy on Mortality in the Acute Respiratory Distress Syndrome
  349. Temporal Hemodynamic Effects of Permissive Hypercapnia Associated with Ideal PEEP in ARDS
  350. Interstitial lung disease in primary Sjögren's syndrome. Clinical-pathological evaluation and response to treatment.
  351. Beneficial effects of the "open lung approach" with low distending pressures in acute respiratory distress syndrome. A prospective randomized study on mechanical ventilation.
  352. The role of deep roots in the hydrological and carbon cycles of Amazonian forests and pastures
  353. A new heterochromatin banding pattern revealed by modified HKG banding technique in maize chromosomes
  354. An Air Drying Technique for Maize Chromosomes without Enzymatic Maceration
  355. Nuclear/cytoplasmic ratio correlates strongly with survival in non-disseminated neuroendocrine carcinoma of the lung
  356. Volume-Assured Pressure Support Ventilation (VAPSV)
  357. Flow and volume dependence of respiratory system mechanics during constant flow ventilation in normal subjects and in adult respiratory distress syndrome
  358. Respiratory Failure Caused by Adiaspiromycosis
  359. Obstructive respiratory failure in cicatricial pemphigoid.
  360. Pulmonary histiocytosis X: comparison of radiographic and CT findings.
  361. Concurrent Churg-Strauss Syndrome and Temporal Arteritis in a Young Patient with Pulmonary Nodules
  362. Histochemical Evaluation of Lung Collagen Content in Acute and Chronic Interstitial Diseases
  363. Solitary plasmacytoma of the trachea treated by loop resection and laser therapy.
  364. Behçet's disease: a rare case of simultaneous pulmonary and cerebral involvement
  365. Congenital bronchobiliary fistula: first case in an adult.
  366. Behçet's disease: A rare case of simultaneous pulmonary and cerebral involvement
  367. Changes in the Pulmonary Glucocorticoid Receptor Content in the Course of Interstitial Disease
  368. Steroid Receptors in Pulmonary Lymphangiomyomatosis